Skip to content

Benjamin Doranz

Director at Optimeos.

Earliest Form D on file: Jun 2026

Filed Jun 3, 2026

Optimeos

Non-viral nanoparticles for delivering RNA and biologics

Biotech, Princeton NJ

Named, Director.

$1M

sold of $2M offered

Form D

Network

At Optimeos

3 people